Triamterene And Hydrochlorothiazide Tablet
Product Images NDC 51407-286

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 51407-286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407 286 01lb

51407 286 01lb
This is a description of a medication containing Triamterene and Hydrochlorothiazide. Each tablet contains 37.5mg and 25mg of the respective compounds. Dosage information is available in the prescribing information. The medication should be stored at room temperature, protected from light, and in a tight, light-resistant container with a child-resistant closure. The medication should be kept out of reach of children. The tablets are manufactured by Apotex Inc. and marketed by GSMS, Incorporated. The NDC number is 51407-286-01.*
FDA Label Image

Structure-hydrochlorothiazide (Structure Hydrochlorothiazide)

Structure-hydrochlorothiazide (Structure Hydrochlorothiazide)
This text appears to be a chemical compound identifier, specifically the CHCIN compound. It also provides information about the molecular weight of the compound, which is 297.73.*
FDA Label Image

Structure-triamterene (Structure Triamterene)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.